Innoviva (INVA) Total Debt Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Innoviva | 1.60 Bn | 992.84 Mn | 75.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7.82% |
| Dec 31, 2025 | -7.74% |
| Sep 30, 2025 | -7.66% |
| Jun 30, 2025 | 3.32% |
| Mar 31, 2025 | 3.43% |
| Dec 31, 2024 | 3.52% |
| Sep 30, 2024 | 2.87% |
| Jun 30, 2024 | 2.95% |
| Mar 31, 2024 | 3.03% |
| Dec 31, 2023 | 3.11% |
| Sep 30, 2023 | 3.19% |
| Jun 30, 2023 | -1.76% |
| Mar 31, 2023 | -1.70% |
| Dec 31, 2022 | -2.05% |
| Sep 30, 2022 | -2.20% |
| Jun 30, 2022 | -25.41% |
| Mar 31, 2022 | -27.25% |
| Dec 31, 2021 | -11.23% |
| Sep 30, 2021 | -4.01% |
| Jun 30, 2021 | -4.23% |
| Mar 31, 2021 | -4.31% |
| Dec 31, 2020 | -4.37% |
| Sep 30, 2020 | -4.75% |
| Jun 30, 2020 | -4.64% |
| Mar 31, 2020 | -4.49% |
| Dec 31, 2019 | -4.37% |
| Sep 30, 2019 | -3.32% |
| Jun 30, 2019 | -2.99% |
| Dec 31, 2018 | 57.11% |
| Mar 31, 2017 | 716.34% |
| Dec 31, 2016 | 535.66% |
| Sep 30, 2016 | 435.83% |
| Jun 30, 2016 | 395.56% |
| Dec 31, 2015 | 345.42% |